Fortunis capital investment in biotec Stemson makes the headlines on tv

Fortunis Capital and Allergan Aesthetics’ £6million investment to support Stemson Therapeutic’s ground-breaking solution to cure hair loss made the headlines on Local TV, a major UK network that reaches 4.5million viewers a month.

Interviewer Emily Bonner asked Sir Andrew Ross, our director of investments, about Stemson’s mission to restore human hair growth using the patient’s own cells to generate new hair follicles.